4DMedical revenue and financials

4DX · ASX · AUD

Compare 4DMedical
$2.19Change from previous close: −4.78%Absolute change: −$0.11

Close · November 16, 2026

In the fiscal year ended June 2026, 4DMedical reported revenue of $7.06M (+20.64% year over year). The net loss was $204.44M.

Annual revenue · 2026: $7.06M
  1. $1.05M2022
  2. $718.58K2023
  3. $3.75M2024
  4. $5.85M2025
  5. $7.06M2026

Fiscal year ending in June. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+20.64%
FY to Jun 2026 vs FY to Jun 2025
Net margin
-2,895.1%
FY to Jun 2025: -513.7%

How 4DMedical is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of AUD; per-share values in AUD; shares in millions.

Income statement · Annual
ItemFY to Jun 2026FY to Jun 2025FY to Jun 2024FY to Jun 2023FY to Jun 2022
Total revenue7.15.93.80.71.1
Cost of revenue0.40.50.20.00.8
Gross profit6.65.43.50.70.3
Selling, general and administrative39.232.127.823.719.2
Research and development—0.90.74.0—
Operating income-57.5-47.5-45.0-44.6-36.8
EBIT-57.5-47.5-45.0-44.6-36.8
EBITDA-56.0-46.0-43.9-43.8-36.3
Interest expense1670.30.30.30.2
Pre-tax income-206-30.2-35.9-31.1-24.5
Income tax-1.1-0.10.00.30.0
Net income-204-30.1-36.0-31.5-24.6
Net income to common shareholders-204-30.1-36.0-31.5-24.6
Basic EPS-0.38-0.07-0.10-0.10-0.08
Diluted EPS-0.38-0.07-0.11-0.10-0.08
Average shares (basic)537424370300295
Average shares (diluted)594521370300318

Companies in the group: same industry, similar size